Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report.

Sushil Khanal, Rohit Kumar Chaudhary, Kripa Kc, Supriya Lamichhane, Sarita Kathayat, Subash Prasad Acharya

Open access · diamondAbstract readCase Reports

In one paragraph

Article in Annals of medicine and surgery (2012), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.5field-weighted citation impact, top 40% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

Status Epilepticus is Not Uncommon as the First Presentation of PRES the Diagnosis of Which Requires the Exclusion of All Differential Diagnoses.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2023
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sushil KhanalDepartment of Critical Care, Grande International Hospital, Kathmandu, Nepal.

Rohit Kumar ChaudharyDepartment of Critical Care, Grande International Hospital, Kathmandu, Nepal.

Kripa KcDepartment of Critical Care, Grande International Hospital, Kathmandu, Nepal.

Supriya LamichhaneDepartment of Critical Care, Grande International Hospital, Kathmandu, Nepal.

Sarita KathayatDepartment of Critical Care, Grande International Hospital, Kathmandu, Nepal.

Subash Prasad AcharyaDepartment of Critical Care, Grande International Hospital, Kathmandu, Nepal.

Grande International Hospital · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•Posterior reversible encephalopathy syndrome is one of the numerous causes of status epilepticus and it should be kept in mind while encountering such clinical scenario.•Mycophenolate mofetil can be contributory cause of PRES.•Prompt recognition and timely intervention is a key to full recovery without any residual neurological deficits after refractory status epilepticus.

Indexed as

Mycophenolate mofetilPosterior reversible encephalopathy syndromeStatus epilepticus

Identifiers

PMID33643649

DOI10.1016/j.amsu.2021.01.095

PMCPMC7895702

OpenAlexW3127332389

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.